Publication | Closed Access
A phase III trial of bevacizumab with IV versus IP chemotherapy for ovarian, fallopian tube, and peritoneal carcinoma: An NRG Oncology Study
41
Citations
0
References
2016
Year
Nrg Oncology StudyGastrointestinal OncologyMedicineMetronomic TherapyPhase Iii TrialFallopian TubeSurgeryCancer TreatmentOncologyRadiation OncologyGynecology OncologyOvarian Cancer
No additional data available for this publication yet. Check back later!